A rapid decrease in the expression of DMT1 and Dcytb but not Ireg1 or hephaestin explains the mucosal block

D M Frazer1, S J Wilkins, E M Becker

  • 1Joint Clinical Sciences Program, the Queensland Institute of Medical Research and the University of Queensland, PO Royal Brisbane Hospital, Brisbane, Queensland 4029, Australia.

Gut
|February 14, 2003
PubMed
Abstract

Insights

A large oral iron dose reduces subsequent iron absorption by decreasing brush border transporter expression, indicating local regulation of intestinal iron uptake.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Nutritional Science

Background:

  • Oral iron administration can inhibit absorption of subsequent doses, a phenomenon termed mucosal block.
  • Understanding the molecular mechanisms of mucosal block is key to regulating intestinal iron absorption.

Purpose of the Study:

  • To investigate the impact of an oral iron bolus on duodenal iron transport gene expression in rats.
  • To correlate these molecular changes with alterations in iron absorption.

Main Methods:

  • Rats received an oral iron dose, followed by analysis of duodenal expression of DMT1, Dcytb, Ireg1, and hephaestin via molecular assays.
  • Iron absorption was quantified using radioactive 59Fe tracer.

Main Results:

  • Oral iron led to decreased intestinal iron absorption, linked to elevated enterocyte iron levels (ferritin, IRP activity).
  • Brush border transporters Dcytb and IRE-containing DMT1 mRNA and protein levels significantly decreased.
  • Basolateral transporters Ireg1 and hephaestin showed no significant changes in expression.

Conclusions:

  • Enterocyte iron levels locally regulate brush border iron transport components.
  • Systemic iron stimuli primarily impact basolateral iron transport molecules, supporting the mucosal block hypothesis.

Related Concept Videos

The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...